Nishimura K, Kawada M, Suehiro T, Yamano T, Hashimoto K
Second Department of Internal Medicine, Kochi Medical School.
Nihon Jinzo Gakkai Shi. 1992 Oct;34(10):1087-94.
The activities of N-acetyl-beta-D-glucosaminidase (NAG), gamma-glutamyl-transpeptidase (gamma-GTP) and NAG isoenzyme were measured in the urine of 20 patients with multiple myeloma (IgG/IgA type/Bense Jones type; 15/1/4 cases) and 25 healthy controls to evaluate these activities as indicators of renal disturbance in multiple myeloma. NAG isoenzyme fractions in urine were measured by agarose electrophoresis-m-cresol sulfonphthaleinyl-NAG reaction. Mean urinary NAG activity in the patients with myeloma was significantly higher than that in the controls (20.1 +/- 3.3 vs 4.3 +/- 0.3U/g. cr; p < 0.001). Urinary NAG activity in these patients correlated positively with the dose (mg/g. cr) of urinary protein (r = 0.755; p < 0.01), most of which were considered to be light chain protein, but not with creatinine clearance. Each urinary NAG isoenzyme fraction (NAG-1, -2, -3) was higher in the patients than that in the controls, and especially NAG-2 fraction (A form) showed a highly positive correlation with the dose of urinary protein. Urinary gamma-GTP activity in the patients did not differ from that in the controls, but urinary NAG/gamma-GTP ratio was higher in the patients, and reversely correlated with creatinine clearance (r = -0.721; p < 0.01). It is suggested that the elevation of urinary NAG activity results from the damage of lysosome in proximal tubular cells by urinary light chain protein and its degradation products. Therefore, urinary NAG activity may be a good index for proximal tubular disturbance, and NAG/gamma-GTP ratio may be an index for the extensive damage of nephrons in addition to the damage of tubular cells in multiple myeloma.
检测了20例多发性骨髓瘤患者(IgG/IgA型/本-周蛋白型;15/1/4例)和25名健康对照者尿液中N-乙酰-β-D-氨基葡萄糖苷酶(NAG)、γ-谷氨酰转肽酶(γ-GTP)的活性及NAG同工酶,以评估这些活性作为多发性骨髓瘤肾损害指标的价值。采用琼脂糖电泳-间甲酚磺酞基-NAG反应法检测尿液中NAG同工酶组分。骨髓瘤患者尿NAG平均活性显著高于对照组(20.1±3.3 vs 4.3±0.3U/g·cr;p<0.001)。这些患者的尿NAG活性与尿蛋白剂量(mg/g·cr)呈正相关(r=0.755;p<0.01),其中大部分被认为是轻链蛋白,但与肌酐清除率无关。患者尿液中各NAG同工酶组分(NAG-1、-2、-3)均高于对照组,尤其是NAG-2组分(A形式)与尿蛋白剂量呈高度正相关。患者尿γ-GTP活性与对照组无差异,但患者尿NAG/γ-GTP比值较高,且与肌酐清除率呈负相关(r=-0.721;p<0.01)。提示尿NAG活性升高是由于尿轻链蛋白及其降解产物对近端肾小管细胞溶酶体的损伤所致。因此,尿NAG活性可能是近端肾小管损害的良好指标,而NAG/γ-GTP比值可能是多发性骨髓瘤中除肾小管细胞损伤外肾单位广泛损害的指标。